Quick Takeaways
- Invesco Ltd. filed SCHEDULE 13G for ADMA Biologics Inc Common Stock (ADMA).
- Disclosed ownership: 5.4%.
- Date of event: 31 Mar 2025.
Invesco Ltd. - 31 Mar 2025 SCHEDULE 13G Report for ADMA Biologics Inc Common Stock (ADMA)
- Filing Manager
- Invesco Ltd.
- Reporting Manager
- Invesco Ltd.
- Security
- ADMA Biologics Inc Common Stock
- Symbol
- ADMA
- Shares outstanding
- 238,276,000 shares
- Disclosed Ownership
- 12,866,904 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 09 May 2025, 16:14:39 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 07 Feb 2025
- Next filing
- 12 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Invesco Ltd. disclosed 5.4% ownership in ADMA Biologics Inc Common Stock (ADMA) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 07 Feb 2025.
- Current filing was accepted on 09 May 2025, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 5.4% | 12,866,904 | 12,179,547 | 0 | Robert R. Leveille | Global Head of Compliance |